Skanska Awarded $125M to Complete Life Science Facility in Woburn

Boston-based Skanska has been awarded a $125-million contract from CONTINUUS Pharmaceuticals to complete a new manufacturing facility in Woburn, MA. Construction activities are underway, and the project is on schedule for completion in the second quarter of 2023.

When completed, the facility will mitigate hospital and pharmacy shortages of critical drugs.

Skanska is building the CONTINUUS facility in an existing 50,000-square-foot shell space and facilitating renovations to the building, including a new two-story, approximately 50,000-square-foot addition with a third-floor penthouse.

Skanska will also construct a new utility structure featuring extensive supporting equipment, as well as a new dunnage system to support a modular air handling unit penthouse. Features of the facility’s functional area include just-in-time warehousing, sampling, weighing, API synthesis spaces, OSD product and aseptic fill-finish spaces, inspection, terminal sterilization, utility generation and support spaces. The site will also include two loading docks, a tank farm, waste tanks and solvent lockers.